Chemotherapy in chronic kidney disease and dialysis

Sabine Karam; Victoria Gutgarts; Ilya Glezerman

doi:10.1016/B978-0-323-54945-5.00028-X

Chemotherapy in chronic kidney disease and dialysis

Sabine Karam, Victoria Gutgarts, Ilya Glezerman

Medicine - Renal and Hypertension Division

Research output: Chapter in Book/Report/Conference proceeding › Chapter

3 Scopus citations

Abstract

This chapter will review available evidence for management of patients with chronic kidney disease and end-stage renal disease who are undergoing anticancer therapy. Both conventional chemotherapy and targeted biological therapies will be reviewed with respect to safety and necessary dose adjustments, to account for the reduced kidney function in this population of patients.

Original language	English (US)
Title of host publication	Onco-Nephrology
Publisher	Elsevier
Pages	183-196.e7
ISBN (Electronic)	9780323549455
ISBN (Print)	9780323549615
DOIs	https://doi.org/10.1016/B978-0-323-54945-5.00028-X
State	Published - Jan 1 2019

Bibliographical note

Publisher Copyright:
© 2020 Elsevier Inc. All rights reserved.

Keywords

Chemotherapy
Chronic kidney disease
Dose adjustment
End-stage renal disease
Pharmacokinetics
Targeted therapy

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Publisher link

10.1016/B978-0-323-54945-5.00028-X

Find It

Find It at U of M Libraries

Cite this

@inbook{ac0c866f60004f3c90999d68e96bc3f3,

title = "Chemotherapy in chronic kidney disease and dialysis",

abstract = "This chapter will review available evidence for management of patients with chronic kidney disease and end-stage renal disease who are undergoing anticancer therapy. Both conventional chemotherapy and targeted biological therapies will be reviewed with respect to safety and necessary dose adjustments, to account for the reduced kidney function in this population of patients.",

keywords = "Chemotherapy, Chronic kidney disease, Dose adjustment, End-stage renal disease, Pharmacokinetics, Targeted therapy",

author = "Sabine Karam and Victoria Gutgarts and Ilya Glezerman",

year = "2019",

month = jan,

day = "1",

doi = "10.1016/B978-0-323-54945-5.00028-X",

language = "English (US)",

isbn = "9780323549615",

pages = "183--196.e7",

booktitle = "Onco-Nephrology",

publisher = "Elsevier",

}

TY - CHAP

T1 - Chemotherapy in chronic kidney disease and dialysis

AU - Karam, Sabine

AU - Gutgarts, Victoria

AU - Glezerman, Ilya

PY - 2019/1/1

Y1 - 2019/1/1

N2 - This chapter will review available evidence for management of patients with chronic kidney disease and end-stage renal disease who are undergoing anticancer therapy. Both conventional chemotherapy and targeted biological therapies will be reviewed with respect to safety and necessary dose adjustments, to account for the reduced kidney function in this population of patients.

AB - This chapter will review available evidence for management of patients with chronic kidney disease and end-stage renal disease who are undergoing anticancer therapy. Both conventional chemotherapy and targeted biological therapies will be reviewed with respect to safety and necessary dose adjustments, to account for the reduced kidney function in this population of patients.

KW - Chemotherapy

KW - Chronic kidney disease

KW - Dose adjustment

KW - End-stage renal disease

KW - Pharmacokinetics

KW - Targeted therapy

UR - http://www.scopus.com/inward/record.url?scp=85093486575&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85093486575&partnerID=8YFLogxK

U2 - 10.1016/B978-0-323-54945-5.00028-X

DO - 10.1016/B978-0-323-54945-5.00028-X

M3 - Chapter

AN - SCOPUS:85093486575

SN - 9780323549615

SP - 183-196.e7

BT - Onco-Nephrology

PB - Elsevier

ER -

Chemotherapy in chronic kidney disease and dialysis

Abstract

Bibliographical note

Keywords

UN SDGs

Publisher link

Find It

Other files and links

Fingerprint

Cite this